ANIP logo

ANI Pharmaceuticals (ANIP) EBIT

annual EBIT:

-$4.61M-$51.42M(-109.85%)
December 31, 2024

Summary

  • As of today (May 21, 2025), ANIP annual earnings before interest & taxes is -$4.61 million, with the most recent change of -$51.42 million (-109.85%) on December 31, 2024.
  • During the last 3 years, ANIP annual EBIT has risen by +$39.53 million (+89.56%).
  • ANIP annual EBIT is now -109.85% below its all-time high of $46.81 million, reached on December 31, 2023.

Performance

ANIP EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPincome statement metrics

quarterly EBIT:

$25.47M+$33.22M(+428.79%)
March 31, 2025

Summary

  • As of today (May 21, 2025), ANIP quarterly earnings before interest & taxes is $25.47 million, with the most recent change of +$33.22 million (+428.79%) on March 31, 2025.
  • Over the past year, ANIP quarterly EBIT has dropped by -$4.46 million (-14.91%).
  • ANIP quarterly EBIT is now -14.91% below its all-time high of $29.93 million, reached on March 31, 2024.

Performance

ANIP quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPincome statement metrics

TTM EBIT:

-$9.07M-$4.46M(-96.83%)
March 31, 2025

Summary

  • As of today (May 21, 2025), ANIP TTM earnings before interest & taxes is -$9.07 million, with the most recent change of -$4.46 million (-96.83%) on March 31, 2025.
  • Over the past year, ANIP TTM EBIT has dropped by -$75.96 million (-113.57%).
  • ANIP TTM EBIT is now -113.57% below its all-time high of $66.89 million, reached on March 31, 2024.

Performance

ANIP TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

ANIP EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-109.8%-14.9%-113.6%
3 y3 years+89.6%+232.1%+86.2%
5 y5 years-128.6%+425.2%-325.8%

ANIP EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-109.8%+89.6%-14.9%+187.3%-113.6%+86.2%
5 y5-year-109.8%+89.6%-14.9%+187.3%-113.6%+86.2%
alltimeall time-109.8%+91.0%-14.9%+187.3%-113.6%+86.2%

ANIP EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
$25.47M(-428.8%)
-$9.07M(+96.8%)
Dec 2024
-$4.61M(-109.8%)
-$7.75M(-73.4%)
-$4.61M(-146.9%)
Sep 2024
-
-$29.17M(-1331.2%)
$9.83M(-82.7%)
Jun 2024
-
$2.37M(-92.1%)
$56.91M(-14.9%)
Mar 2024
-
$29.93M(+347.3%)
$66.89M(+42.9%)
Dec 2023
$46.81M(-235.2%)
$6.69M(-62.6%)
$46.81M(+11.7%)
Sep 2023
-
$17.91M(+45.0%)
$41.90M(+120.2%)
Jun 2023
-
$12.35M(+25.2%)
$19.03M(-448.0%)
Mar 2023
-
$9.86M(+454.6%)
-$5.47M(-84.2%)
Dec 2022
-$34.61M(-21.6%)
$1.78M(-135.9%)
-$34.61M(-44.9%)
Sep 2022
-
-$4.96M(-59.2%)
-$62.80M(+0.5%)
Jun 2022
-
-$12.15M(-37.0%)
-$62.48M(-5.3%)
Mar 2022
-
-$19.28M(-27.0%)
-$65.95M(+49.4%)
Dec 2021
-$44.14M(+167.3%)
-$26.41M(+470.1%)
-$44.14M(+151.5%)
Sep 2021
-
-$4.63M(-70.3%)
-$17.55M(+69.7%)
Jun 2021
-
-$15.62M(-717.4%)
-$10.35M(+68.3%)
Mar 2021
-
$2.53M(+1370.9%)
-$6.15M(-62.8%)
Dec 2020
-$16.51M(-202.4%)
$172.00K(-93.3%)
-$16.51M(-23.1%)
Sep 2020
-
$2.57M(-122.5%)
-$21.46M(+28.2%)
Jun 2020
-
-$11.42M(+45.9%)
-$16.74M(-516.6%)
Mar 2020
-
-$7.83M(+63.8%)
$4.02M(-75.1%)
Dec 2019
$16.12M(-53.7%)
-$4.78M(-165.6%)
$16.12M(-49.4%)
Sep 2019
-
$7.29M(-21.9%)
$31.87M(-8.2%)
Jun 2019
-
$9.34M(+118.6%)
$34.71M(+6.5%)
Mar 2019
-
$4.27M(-61.0%)
$32.60M(-6.3%)
Dec 2018
$34.81M(+22.6%)
$10.97M(+8.2%)
$34.81M(+11.5%)
Sep 2018
-
$10.13M(+40.1%)
$31.22M(+2.3%)
Jun 2018
-
$7.23M(+11.7%)
$30.51M(+0.9%)
Mar 2018
-
$6.48M(-12.2%)
$30.25M(+6.6%)
Dec 2017
$28.38M(+41.9%)
$7.38M(-21.7%)
$28.38M(+27.5%)
Sep 2017
-
$9.43M(+35.1%)
$22.26M(+7.4%)
Jun 2017
-
$6.97M(+51.4%)
$20.74M(+9.5%)
Mar 2017
-
$4.61M(+267.1%)
$18.94M(-5.3%)
Dec 2016
$20.00M(-38.9%)
$1.25M(-84.1%)
$20.00M(-20.0%)
Sep 2016
-
$7.90M(+52.5%)
$25.02M(-2.0%)
Jun 2016
-
$5.18M(-8.6%)
$25.54M(-11.2%)
Mar 2016
-
$5.67M(-9.6%)
$28.77M(-12.1%)
Dec 2015
$32.74M(+62.4%)
$6.27M(-25.6%)
$32.74M(-12.5%)
Sep 2015
-
$8.42M(+0.1%)
$37.40M(+0.6%)
Jun 2015
-
$8.41M(-12.7%)
$37.18M(+41.3%)
Mar 2015
-
$9.63M(-11.9%)
$26.31M(+30.3%)
Dec 2014
$20.17M(+3300.7%)
$10.93M(+33.3%)
$20.20M(+62.6%)
Sep 2014
-
$8.20M(-433.3%)
$12.42M(+146.9%)
Jun 2014
-
-$2.46M(-169.8%)
$5.03M(+35.4%)
Mar 2014
-
$3.52M(+11.7%)
$3.71M(-282.4%)
Dec 2013
$593.00K(-102.2%)
$3.15M(+289.5%)
-$2.04M(-77.7%)
Sep 2013
-
$810.00K(-121.5%)
-$9.11M(-43.4%)
Jun 2013
-
-$3.77M(+69.6%)
-$16.10M(-17.8%)
Mar 2013
-
-$2.23M(-43.3%)
-$19.59M(-28.8%)
Dec 2012
-$27.49M
-$3.92M(-36.5%)
-$27.51M(-8.5%)
Sep 2012
-
-$6.18M(-15.0%)
-$30.07M(-17.5%)
Jun 2012
-
-$7.27M(-28.3%)
-$36.45M(-13.7%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$10.14M(+56.4%)
-$42.25M(-14.1%)
Dec 2011
-$50.93M(+11.9%)
-$6.48M(-48.4%)
-$49.19M(-14.9%)
Sep 2011
-
-$12.56M(-3.9%)
-$57.77M(+2.3%)
Jun 2011
-
-$13.06M(-23.5%)
-$56.45M(+5.3%)
Mar 2011
-
-$17.08M(+13.3%)
-$53.63M(+17.8%)
Dec 2010
-$45.51M(+18.4%)
-$15.07M(+34.1%)
-$45.51M(-17.7%)
Sep 2010
-
-$11.24M(+9.8%)
-$55.28M(+13.0%)
Jun 2010
-
-$10.24M(+14.3%)
-$48.94M(+13.0%)
Mar 2010
-
-$8.96M(-63.9%)
-$43.32M(+12.7%)
Dec 2009
-$38.43M(+113.3%)
-$24.84M(+407.0%)
-$38.43M(+148.8%)
Sep 2009
-
-$4.90M(+6.0%)
-$15.44M(-10.4%)
Jun 2009
-
-$4.62M(+13.7%)
-$17.23M(-4.9%)
Mar 2009
-
-$4.06M(+118.5%)
-$18.13M(+0.5%)
Dec 2008
-$18.01M(+107.5%)
-$1.86M(-72.2%)
-$18.03M(-0.8%)
Sep 2008
-
-$6.69M(+21.3%)
-$18.18M(+33.3%)
Jun 2008
-
-$5.51M(+39.0%)
-$13.64M(+26.8%)
Mar 2008
-
-$3.97M(+97.1%)
-$10.76M(+24.0%)
Dec 2007
-$8.68M(-352.3%)
-$2.01M(-6.3%)
-$8.68M(-366.2%)
Sep 2007
-
-$2.15M(-18.4%)
$3.26M(-28.2%)
Jun 2007
-
-$2.63M(+39.3%)
$4.54M(-6.9%)
Mar 2007
-
-$1.89M(-119.0%)
$4.88M(+41.8%)
Dec 2006
$3.44M(-137.0%)
$9.93M(-1244.3%)
$3.44M(-141.5%)
Sep 2006
-
-$867.50K(-62.2%)
-$8.28M(-11.6%)
Jun 2006
-
-$2.30M(-31.0%)
-$9.37M(-4.0%)
Mar 2006
-
-$3.32M(+85.5%)
-$9.76M(+4.9%)
Dec 2005
-$9.30M(-24.2%)
-$1.79M(-8.4%)
-$9.30M(-20.6%)
Sep 2005
-
-$1.96M(-27.1%)
-$11.72M(-7.8%)
Jun 2005
-
-$2.68M(-6.4%)
-$12.72M(+0.4%)
Mar 2005
-
-$2.87M(-31.9%)
-$12.66M(+3.2%)
Dec 2004
-$12.27M(+102.9%)
-$4.21M(+42.5%)
-$12.27M(+25.1%)
Sep 2004
-
-$2.95M(+12.3%)
-$9.80M(+18.3%)
Jun 2004
-
-$2.63M(+6.4%)
-$8.29M(+13.8%)
Mar 2004
-
-$2.47M(+41.6%)
-$7.29M(+20.3%)
Dec 2003
-$6.05M(+58.7%)
-$1.75M(+21.4%)
-$6.06M(+28.3%)
Sep 2003
-
-$1.44M(-11.6%)
-$4.72M(+15.6%)
Jun 2003
-
-$1.63M(+30.8%)
-$4.08M(+3.2%)
Mar 2003
-
-$1.24M(+202.6%)
-$3.96M(+3.7%)
Dec 2002
-$3.81M(+36.8%)
-$411.40K(-48.6%)
-$3.82M(-21.2%)
Sep 2002
-
-$801.00K(-46.7%)
-$4.85M(+28.9%)
Jun 2002
-
-$1.50M(+36.2%)
-$3.76M(+20.6%)
Mar 2002
-
-$1.10M(-23.4%)
-$3.12M(+13.9%)
Dec 2001
-$2.79M(-19.0%)
-$1.44M(-603.1%)
-$2.73M(+34.1%)
Sep 2001
-
$286.30K(-133.3%)
-$2.04M(-32.2%)
Jun 2001
-
-$858.90K(+19.0%)
-$3.01M(-16.1%)
Mar 2001
-
-$722.00K(-3.0%)
-$3.58M(+6.1%)
Dec 2000
-$3.44M(+114.2%)
-$744.40K(+9.3%)
-$3.38M(+28.3%)
Sep 2000
-
-$680.90K(-52.5%)
-$2.63M(+34.9%)
Jun 2000
-
-$1.43M(+177.8%)
-$1.95M(+131.5%)
Mar 2000
-
-$516.20K(+58.2%)
-$842.40K(+158.2%)
Dec 1999
-$1.60M(-39.7%)
-
-
Jun 1999
-
-$326.20K
-$326.20K
Dec 1998
-$2.66M
-
-

FAQ

  • What is ANI Pharmaceuticals annual earnings before interest & taxes?
  • What is the all time high annual EBIT for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals annual EBIT year-on-year change?
  • What is ANI Pharmaceuticals quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals quarterly EBIT year-on-year change?
  • What is ANI Pharmaceuticals TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals TTM EBIT year-on-year change?

What is ANI Pharmaceuticals annual earnings before interest & taxes?

The current annual EBIT of ANIP is -$4.61M

What is the all time high annual EBIT for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high annual earnings before interest & taxes is $46.81M

What is ANI Pharmaceuticals annual EBIT year-on-year change?

Over the past year, ANIP annual earnings before interest & taxes has changed by -$51.42M (-109.85%)

What is ANI Pharmaceuticals quarterly earnings before interest & taxes?

The current quarterly EBIT of ANIP is $25.47M

What is the all time high quarterly EBIT for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high quarterly earnings before interest & taxes is $29.93M

What is ANI Pharmaceuticals quarterly EBIT year-on-year change?

Over the past year, ANIP quarterly earnings before interest & taxes has changed by -$4.46M (-14.91%)

What is ANI Pharmaceuticals TTM earnings before interest & taxes?

The current TTM EBIT of ANIP is -$9.07M

What is the all time high TTM EBIT for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high TTM earnings before interest & taxes is $66.89M

What is ANI Pharmaceuticals TTM EBIT year-on-year change?

Over the past year, ANIP TTM earnings before interest & taxes has changed by -$75.96M (-113.57%)
On this page